- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4786EUR$4,950USD£4,111GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- January 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- March 2024
- 199 Pages
Global
From €3262EUR$3,374USD£2,802GBP
€3624EUR$3,749USD£3,113GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- December 2023
- 200 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- November 2023
- 138 Pages
Global
From €2416EUR$2,499USD£2,075GBP
- Report
- March 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- June 2023
- 165 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- January 2024
- 200 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- October 2023
- 145 Pages
Global
From €3045EUR$3,150USD£2,616GBP
- Report
- January 2024
- 120 Pages
Global
€4829EUR$4,995USD£4,148GBP
- Report
- January 2022
- 197 Pages
Global
From €6555EUR$6,780USD£5,630GBP
- Report
- August 2022
- 115 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2022
- 115 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- March 2021
- 45 Pages
Global
From €2412EUR$2,495USD£2,072GBP
- Report
- February 2020
- 137 Pages
Global
From €7729EUR$7,995USD£6,639GBP
Ulcerative Colitis (UC) is a type of Inflammatory Bowel Disease (IBD) that affects the large intestine. It is characterized by inflammation and ulceration of the inner lining of the colon and rectum. Symptoms of UC include abdominal pain, bloody diarrhea, fatigue, and weight loss. Treatment options for UC include medications, lifestyle changes, and surgery.
The UC market is a subset of the larger Gastroenterology market. It is a growing market, driven by an increasing prevalence of IBD and the development of new treatments. The market is highly competitive, with a number of companies offering treatments for UC.
Some of the companies in the UC market include AbbVie, Allergan, AstraZeneca, Janssen, Pfizer, and Takeda. Show Less Read more